Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 24;17(15):5328.
doi: 10.3390/ijerph17155328.

On the True Number of COVID-19 Infections: Effect of Sensitivity, Specificity and Number of Tests on Prevalence Ratio Estimation

Affiliations

On the True Number of COVID-19 Infections: Effect of Sensitivity, Specificity and Number of Tests on Prevalence Ratio Estimation

Eitan Altman et al. Int J Environ Res Public Health. .

Abstract

In this paper, a formula for estimating the prevalence ratio of a disease in a population that is tested with imperfect tests is given. The formula is in terms of the fraction of positive test results and test parameters, i.e., probability of true positives (sensitivity) and the probability of true negatives (specificity). The motivation of this work arises in the context of the COVID-19 pandemic in which estimating the number of infected individuals depends on the sensitivity and specificity of the tests. In this context, it is shown that approximating the prevalence ratio by the ratio between the number of positive tests and the total number of tested individuals leads to dramatically high estimation errors, and thus, unadapted public health policies. The relevance of estimating the prevalence ratio using the formula presented in this work is that precision increases with the number of tests. Two conclusions are drawn from this work. First, in order to ensure that a reliable estimation is achieved with a finite number of tests, testing campaigns must be implemented with tests for which the sum of the sensitivity and the specificity is sufficiently different than one. Second, the key parameter for reducing the estimation error is the number of tests. For a large number of tests, as long as the sum of the sensitivity and specificity is different than one, the exact values of these parameters have very little impact on the estimation error.

Keywords: Covid-19; SARS-CoV-2; cross-sectional studies; false positive and false negative probabilities; molecular, serological and medical imaging diagnostics; number of infections; policy-making and testing campaigns; prevalence ratio; sensitivity and specificity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
A SARS-CoV-2 test represented by a random transformation from {I,S} into {I,S} via the conditional probability distribution PY|X.
Figure 2
Figure 2
Relation between the input vector x=(x1,x2,,xn){I,S}n (state of the individuals); the output vector y=(y1,y2,,yn){I,S}n (result of the tests); the calculation of the fraction of positive tests P¯Y(n)(I) in (3); and estimation of the prevalence ratio P^X(n)(I) in (8a).
Figure 3
Figure 3
Population in which the fraction of individuals infected with SARS-CoV-2 is PX = 0.4 and n = 10, 000 individuals are tested (Example 1).
Figure 4
Figure 4
Population in which the fraction of individuals infected with SARS-CoV-2 is PX = 0.4 and n = 10, 000 individuals are tested (Example 1).
Figure 5
Figure 5
Population in which the fraction of individuals infected with SARS-CoV-2 is PX = 0.4 and n = 100, 000 individuals are tested (Example 2).
Figure 6
Figure 6
Population in which the fraction of individuals infected with SARS-CoV-2 is PX = 0.4 and n = 100, 000 individuals are tested (Example 2).
Figure 7
Figure 7
Population in which the fraction of individuals infected with SARS-CoV-2 is PX = 0.4 and n = 100, 000, 000 individuals are tested (Example 3).
Figure 8
Figure 8
Population in which the fraction of individuals infected with SARS-CoV-2 is PX = 0.4 and n = 100, 000, 000 individuals are tested (Example 3).

References

    1. Brauer F., Castillo-Chávez C., Feng Z. Mathematical Models in Epidemiology. 1st ed. Springer; New York, NY, USA: 2019.
    1. Rothman K.J., Greenland S. Modern Epidemiology. 3rd ed. Lippincott Williams & Wilkins; Philadelphia, PA, USA: 2008.
    1. Vinh D.B., Zhao X., Kiong K.L., Guo T., Jozaghi Y., Yao C., Kelley J.M., Hanna E. Overview of COVID-19 testing and implications for otolaryngologists. Head Neck. 2020:1–5. doi: 10.1002/hed.26213. - DOI - PMC - PubMed
    1. Haute Autorité de Santé . Place des Tests Sérologiques Rapides (TDR, TROD, Autotests) dans la stratégie de Prise en Charge de la Maladie COVID—19. Haute Autorité de Santé (HAS); Saint-Denis La Plaine, France: 2020. Technical Report.
    1. Kelly J.C., Dombrowksi M., O’neil-Callahan M., Kernberg A.S., Frolova A.I., Stout M.J. False-Negative COVID-19 Testing: Considerations in Obstetrical Care. Am. J. Obstet. Gynecol. MFM. 2020:100130. doi: 10.1016/j.ajogmf.2020.100130. - DOI - PMC - PubMed

LinkOut - more resources